Holly Brown

A phase Ib study of MK-3475 in patients with human papillomavirus (HPV)-associated and non-HPV–associated head and neck (H/N) cancer.

Tanguy Y. Seiwert, Barbara Burtness, Jared Weiss et al. · Journal of Clinical Oncology · 2014 · 128 citations

Immunology, Immunoediting, Pathology +26

A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors

Francesco Atzori, Josep Tabernero, Andrés Cervantes et al. · Clinical Cancer Research · 2011 · 120 citations · Full text

Implementation and Evaluation of a Nursing Home Fall Management Program

Kimberly J. Rask, Patricia A. Parmelee, Jo Taylor et al. · Journal of the American Geriatrics Society · 2007 · 86 citations

Pembrolizumab Given Concomitantly with Chemoradiation and as Maintenance Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: KEYNOTE-412

Jean‐Pascal Machiels, Yungan Tao, Barbara Burtness et al. · Future Oncology · 2020 · 57 citations · Full text

Neoadjuvant Therapy, Pathology, Metronomic Chemotherapy +17

A phase I, pharmacokinetic (PK) and pharmacodynamic (PD) study of weekly (qW) MK-0646, an insulin-like growth factor-1 receptor (IGF1R) monoclonal antibody (MAb) in patients (pts) with advanced solid tumors

Francesco Atzori, Josep Tabernero, Andrés Cervantes et al. · Journal of Clinical Oncology · 2008 · 55 citations

Igf1r Activation, Immunology, Pathology +18